STOCK TITAN
  1. Home
  2. News
  3. SOLCF

SOL Global Investments Corp - SOLCF STOCK NEWS

Welcome to our dedicated news page for SOL Global Investments (Ticker: SOLCF), a resource for investors and traders seeking the latest updates and insights on SOL Global Investments.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect SOL Global Investments's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of SOL Global Investments's position in the market.

News
SOL Global Announces Financial Results for Fiscal 2023
Rhea-AI Summary
SOL Global Investments Corp. reports audited financial results for the year ended November 30, 2023, showing a net loss decrease of $263 million compared to the previous year. The company's total unrealized and realized losses from investments also saw favorable changes. The Net Asset Value per share decreased from $1.17 to $0.14. SOL Global highlighted operational updates and investments in companies like Damon Motors, Kiwi Campus, Tevva Motors, Navier, Core Scientific, Zapata AI, Build a Rocket Boy, Jones Soda, Simply Better Brands Corp, and House of Lithium. The company also shared a real estate update on a prestigious residential address in Wynwood.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.22%
Tags
earnings
-
News
SOL Global Announces Update on Portfolio Companies
Rhea-AI Summary
SOL Global Investments Corp. announces business updates on its portfolio companies, including Core Scientific, Inc., Build a Rocket Boy, Big League Food Company, and CITYROW Holdings, Inc. Core Scientific emerges from Chapter 11 reorganization, Build a Rocket Boy raises $110 million, Big League Food Company formed from a merger, and WaterRower to acquire CITYROW.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
31.15%
Tags
none
-
News
SOL Global Changes Auditor and Provides Corporate Update
Rhea-AI Summary
SOL Global Investments Corp. (CSE: SOL) (OTC Pink: SOLCF) (FSE: 9SB) announces a change of auditors, nomination of John Zorbas to the Board, grant of DSUs, and updates on Damon Motors. The company also entered into an intercreditor agreement and received an advance from the First Lien Lender.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.76%
Tags
none
News
SOL Global Announces Third Quarter 2023 Financial Results
Rhea-AI Summary
SOL Global Investments Corp. announces unaudited financial results for Q3 2023. Net loss decreased by $154.5 million compared to the same period last year. Total loss from investments decreased by $173.0 million. NAV per share is $0.72.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15.04%
Tags
earnings
-
News
SOL Global Announces Portfolio Company Damon Motors Entered into Business Combination to List on Nasdaq
Rhea-AI Summary
Damon Motors, a portfolio company of SOL Global Investments, is set to list on the Nasdaq after completing a reverse merger with Inpixon's spin-off entity, Grafiti Holding. The enterprise value of Damon is estimated to be between $224 million and $284 million. Damon has received $85 million in pre-production consumer reservations for its HyperSport motorcycles.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.01%
Tags
none
-
News
SOL Global Announces Portfolio Company Andretti Acquisition to Enter into Business Combination with Zapata AI
Rhea-AI Summary
SOL Global announced a business combination agreement between Andretti Acquisition and Zapata AI. SOL Global invested $3.456 million and will hold 1.208 million shares post-transaction. The pro forma equity value of the combined company is expected to be between $281 million and $365 million. The transaction is expected to close in Q1 2024. Tevva Motors also announced a proposed merger with ElectraMeccanica. SOL Global invested $14.5 million and expects both transactions to close by Q1 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.03%
Tags
acquisition AI
News
SOL Global Provides Interim Unaudited Financials for the Second Quarter Ended May 2023
Rhea-AI Summary
SOL Global Investments Corp. (CSE: SOL) (OTC Pink: SOLCF) (FSE: 9SB) reported unaudited financial results for Q2 2023, showing a favorable change in net loss from the previous year, with a focus on operational efficiency. Portfolio highlights include Damon Motors, Kiwi Campus, Tevva Motors, Navier, Core Scientific, Simply Better Brands, and Jones Soda Co. The outlook for 2023 includes expected consolidated net sales to exceed $80 million and gross margin to be between 58% and 60%.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18.57%
Tags
none
-
News
SOL Global Announces Board Changes and Business Update
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15.07%
Tags
none
-
News
SOL Global Provides Interim Unaudited Financials for the Third Quarter Ended August 31, 2022
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.7%
Tags
none
News
SOL Global Continues Principal Re-payments Towards $50 Million Credit Facility
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.75%
Tags
none
Stock SOLCF logo
SOL Global Investments Corp

OTC:SOLCF

SOLCF Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

SOLCF Stock Data

1.39M
49.87M
8.01%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Canada
Toronto

About SOLCF

scythian is a pharmaceutical development company currently undertaking pre-clinical testing at the university of miami on a combination drug therapy for the treatment of traumatic brain injury ("tbi") and concussion. tbi happens when there is a major impact to the head or subjected to accelerative forces. it frequently results in both initial damage from the impact itself and significant subsequent damage from inflammation and the body's own immune response. a significant amount of brain injury occurs from the inflammatory and immune response. scythian’s pharmaceutical approach aims to reduce both the inflammation and the immune response by using a combination of two drugs as the acute emergency room or post injury treatment. a broad based u.s. provisional patent application has been filed utilizing drug combinations which affect the endocannabinoid pathway to treat concussions. scythian's second business line is its application to become a licensed producer of medical marijuana in can